InflaRx (IFRX) Earnings Analysis
InflaRx (IFRX) next reports earnings on 2026-08-06, consensus EPS -0.08 USD. Last quarter (2026-05-07) it beat with EPS -0.09 USD vs -0.17 USD est (+47.1%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -2.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does IFRX next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -0.08 USD |
| Revenue estimate | 0.00B |
IFRX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.09 USD | -0.17 USD | +47.1% | Beat |
| 2026-03-19 | -0.17 USD | -0.18 USD | +5.6% | Beat |
| 2025-11-10 | -0.16 USD | -0.16 USD | 0% | Beat |
| 2025-03-20 | -0.09 USD | -0.27 USD | +66.7% | Beat |
| 2024-11-08 | -0.33 USD | -0.27 USD | -22.2% | Miss |
| 2024-08-08 | -0.26 USD | -0.21 USD | -23.8% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
IFRX valuation and analyst view
| Trailing P/E | -2.59 |
|---|---|
| Trailing EPS | -0.59359 USD |
| Price / book | 3.09 |
| Dividend yield | 0.00% |
| Market cap | 0.13B |
| Analyst consensus | Buy (13 buy / 2 hold / 1 sell) |
| Avg price target | 9 USD |
Related research pages
Frequently asked questions
When is InflaRx (IFRX)'s next earnings date?
InflaRx is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -0.08 USD and revenue estimate of 0.00B.
Did IFRX beat earnings last quarter?
In its 2026-05-07 report, IFRX posted EPS of -0.09 USD versus a -0.17 USD estimate — a beat of 47.1%.
What is IFRX's earnings track record?
Over the last 6 reported quarters with consensus data, IFRX beat estimates 4 times (67%).
What is IFRX's current P/E ratio and EPS?
IFRX trades at a trailing P/E of -2.59 on trailing EPS of -0.5935911595362413 USD.
What do analysts rate IFRX?
Analyst consensus is "Buy" across 16 ratings (1 strong buy, 12 buy, 2 hold, 1 sell, 0 strong sell). Average 12-month price target: 9 USD.